Advisories For Registrants
January 18th, 2021
GILENYA (fingolimod) – Risk of Liver Injury
January 7th, 2021
Important Safety Information on SUBOXONE (buprenorphine and naloxone) and the Risk of Overdose or Underdose when Switching Between Dosage Forms or Routes of Administration
January 6th, 2021
Importation of German-labelled Hydromorphon Ethypharm Kalceks (Hydromorphone Hydrochloride Solution for Injection) due to Potential Shortage of Canadian-labelled HYDROmorphone
December 23rd, 2020
Authorization of Moderna COVID-19 Vaccine with English-only Vial and Carton Labels
December 21st, 2020
Bacitracin for Injection (50,000 IU per vial) and the Risk of Nephrotoxicity and Anaphylactic Reactions
December 15th, 2020
ELMIRON (pentosan polysulfate sodium) and the Risk of Pigmentary Maculopathy
December 12th, 2020
Authorization of Pfizer-BioNTech COVID-19 Vaccine with English-only Carton and Vial Labels
December 1st, 2020
Importation of US-labelled Dexrazoxane for Injection distributed by Mylan Pharmaceuticals ULC due to shortage of Canadian-labelled Dexrazoxane
Advisories For The Public
January 8th, 2021
UPDATE-Ranitidine products recalled because of a nitrosamine impurity
December 24th, 2020
GUM Paroex (anti-gingivitis oral rinse) being recalled due to microbial contamination that could lead to respiratory and other infections in patients
December 16th, 2020
Health Canada warns Canadians not to buy COVID-19 vaccines sold online or from unauthorized sources
December 12th, 2020
Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies
December 11th, 2020
Updated-Recall of certain hand sanitizers that may pose health risks
Institute for Safe Medication Practices (ISMP) Canada Safety Bulletin
Year-to-Date
- December 22, 2020 – ISMP Canada Safety Bulletin Volume 20, Issue 11
Safe Medication Use Newsletter
Year-to-Date
- January 14, 2021 – Managing Changes in Your Medication Blister Pack
